Itacitinib + Everolimus in Hodgkin Lymphoma
Itacitinib + Everolimus in Hodgkin Lymphoma
Active, not recruiting · NCT03697408 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Itacitinib + Everolimus in Hodgkin Lymphoma | classic Hodgkin lymphoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-23 | NCT03697408 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania | Philadelphia | United States | 47 |